--- sp.seq_info content (copy to Claude) ---
ID   PSEG_CAMJE              Reviewed;         274 AA.
AC   Q0P8U5;
DE   RecName: Full=UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose hydrolase;
DE            EC=3.6.1.57;
DE   AltName: Full=Pseudaminic acid biosynthesis protein G;
GN   Name=pseG; OrderedLocusNames=Cj1312;
OS   Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 /
OS   NCTC 11168).
OC   Bacteria; Pseudomonadati; Campylobacterota; Epsilonproteobacteria;
OC   Campylobacterales; Campylobacteraceae; Campylobacter.
OX   NCBI_TaxID=192222;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700819 / NCTC 11168;
RX   PubMed=10688204; DOI=10.1038/35001088;
RA   Parkhill J., Wren B.W., Mungall K.L., Ketley J.M., Churcher C.M.,
RA   Basham D., Chillingworth T., Davies R.M., Feltwell T., Holroyd S.,
RA   Jagels K., Karlyshev A.V., Moule S., Pallen M.J., Penn C.W., Quail M.A.,
RA   Rajandream M.A., Rutherford K.M., van Vliet A.H.M., Whitehead S.,
RA   Barrell B.G.;
RT   "The genome sequence of the food-borne pathogen Campylobacter jejuni
RT   reveals hypervariable sequences.";
RL   Nature 403:665-668(2000).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   STRAIN=ATCC 700819 / NCTC 11168;
RX   PubMed=16728396; DOI=10.1074/jbc.m602972200;
RA   Liu F., Tanner M.E.;
RT   "PseG of pseudaminic acid biosynthesis: a UDP-sugar hydrolase as a masked
RT   glycosyltransferase.";
RL   J. Biol. Chem. 281:20902-20909(2006).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH
RP   URIDINE-5'-DIPHOSPHATE, ACTIVE SITE, SUBUNIT, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF HIS-17; TYR-78 AND ASN-255.
RC   STRAIN=ATCC 700819 / NCTC 11168;
RX   PubMed=19483088; DOI=10.1074/jbc.m109.012351;
RA   Rangarajan E.S., Proteau A., Cui Q., Logan S.M., Potetinova Z.,
RA   Whitfield D., Purisima E.O., Cygler M., Matte A., Sulea T.,
RA   Schoenhofen I.C.;
RT   "Structural and functional analysis of Campylobacter jejuni PseG: a udp-
RT   sugar hydrolase from the pseudaminic acid biosynthetic pathway.";
RL   J. Biol. Chem. 284:20989-21000(2009).
CC   -!- FUNCTION: Nucleotide sugar hydrolase that catalyzes the fourth step in
CC       the biosynthesis of pseudaminic acid, a sialic-acid-like sugar that is
CC       used to modify flagellin. Mediates the removal of UDP from C-1 of UDP-
CC       2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose forming 2,4-
CC       diacetamido-2,4,6-trideoxy-beta-L-altropyranose.
CC       {ECO:0000269|PubMed:16728396}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altrose + H2O = 2,4-
CC         diacetamido-2,4,6-trideoxy-beta-L-altrose + UDP + H(+);
CC         Xref=Rhea:RHEA:31803, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:63283, ChEBI:CHEBI:63417; EC=3.6.1.57;
CC         Evidence={ECO:0000269|PubMed:16728396};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=174 uM for UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose
CC         {ECO:0000269|PubMed:16728396};
CC         KM=250 uM for UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose
CC         {ECO:0000269|PubMed:19483088};
CC         Note=kcat is 27 sec(-1) (PubMed:16728396). kcat is 25 sec(-1)
CC         (PubMed:19483088). {ECO:0000269|PubMed:16728396,
CC         ECO:0000269|PubMed:19483088};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:19483088}.
CC   -!- SIMILARITY: Belongs to the PseG family. {ECO:0000305}.
DR   EMBL; AL111168; CAL35426.1; -; Genomic_DNA.
DR   PIR; E81274; E81274.
DR   RefSeq; WP_002830499.1; NZ_SZUC01000001.1.
DR   RefSeq; YP_002344702.1; NC_002163.1.
DR   PDB; 3HBM; X-ray; 1.80 A; A=1-274.
DR   PDB; 3HBN; X-ray; 1.85 A; A=1-274.
DR   PDBsum; 3HBM; -.
DR   PDBsum; 3HBN; -.
DR   AlphaFoldDB; Q0P8U5; -.
DR   SMR; Q0P8U5; -.
DR   IntAct; Q0P8U5; 6.
DR   STRING; 192222.Cj1312; -.
DR   PaxDb; 192222-Cj1312; -.
DR   EnsemblBacteria; CAL35426; CAL35426; Cj1312.
DR   GeneID; 905604; -.
DR   KEGG; cje:Cj1312; -.
DR   PATRIC; fig|192222.6.peg.1294; -.
DR   eggNOG; COG3980; Bacteria.
DR   HOGENOM; CLU_023406_0_0_7; -.
DR   OrthoDB; 9788924at2; -.
DR   BRENDA; 3.6.1.57; 1087.
DR   EvolutionaryTrace; Q0P8U5; -.
DR   Proteomes; UP000000799; Chromosome.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.11190; -; 1.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 1.
DR   InterPro; IPR020023; PseG.
DR   NCBIfam; TIGR03590; PseG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Reference proteome.
FT   CHAIN           1..274
FT                   /note="UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-
FT                   altropyranose hydrolase"
FT                   /id="PRO_0000418931"
FT   ACT_SITE        17
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:19483088"
FT   BINDING         15..16
FT                   /ligand="substrate"
FT   BINDING         143
FT                   /ligand="substrate"
FT   BINDING         234..235
FT                   /ligand="substrate"
FT   BINDING         239
FT                   /ligand="substrate"
FT   MUTAGEN         17
FT                   /note="H->F,L: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19483088"
FT   MUTAGEN         17
FT                   /note="H->N: Strongly impaired catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19483088"
FT   MUTAGEN         78
FT                   /note="Y->F: Impaired catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19483088"
FT   MUTAGEN         255
FT                   /note="N->A: Impaired catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19483088"
FT   STRAND          3..6
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   TURN            11..13
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           16..25
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          29..35
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           43..45
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          50..52
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          54..56
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           58..68
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          71..75
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           82..92
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          95..99
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          109..113
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           120..123
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   TURN            124..126
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          132..136
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           137..139
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           144..149
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          158..163
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:3HBN"
FT   HELIX           172..179
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          186..190
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           197..205
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          208..215
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           219..224
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          226..234
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           235..242
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          247..250
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           254..256
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   HELIX           257..265
FT                   /evidence="ECO:0007829|PDB:3HBM"
FT   STRAND          269..271
FT                   /evidence="ECO:0007829|PDB:3HBM"
SQ   SEQUENCE   274 AA;  31319 MW;  A65BF88D58502257 CRC64;
//

--- End of sp.seq_info ---

--- species summary (copy to Claude) ---
Number  Rank    Taxon
9	5	Paenibacillaceae
12	5	Bacillaceae
22	4	Bacillales
9	3	Alphaproteobacteria
22	3	Bacilli
15	3	Gammaproteobacteria
11	3	Clostridia
35	2	Bacillota
29	2	Pseudomonadota
38	1	Bacillati
37	1	Pseudomonadati
75	0	Bacteria
Total of 75 proteins found

--- End of species summary ---

--- Domain architectures (copy to Claude) ---
A0A063Y9Y9	PSEUDAMINIC ACID CYTIDYLY     50.2    1.5e-09   2   2.3   0.0
	Q0P8U5_TED01              	    62	   170	    33.7
	Q0P8U5_TED01              	    11	    66	    14.5
	PF04101	Glyco_tran_28_C 	   195	   345	    30.1

A0A089LY67	GLYCOSYL TRANSFERASE FAMI     57.5    8.2e-12   1   2.3   0.1
	Q0P8U5_TED01              	     4	   162	    53.6
	PF04101	Glyco_tran_28_C 	   185	   347	    39.5

A0A098M951	GLYCOSYL TRANSFERASE FAMI     55.0    4.9e-11   1   2.5   0.7
	Q0P8U5_TED01              	     4	   163	    49.9
	PF04101	Glyco_tran_28_C 	   186	   348	    24.4

A0A0A3INQ6	PSEUDAMINIC ACID BIOSYNTH     50.3    1.4e-09   1   1.9   0.1
	Q0P8U5_TED01              	     5	   136	    48.7

A0A0A6VGT7	GLYCOSYL TRANSFERASE FAMI     57.7    7.3e-12   1   2.4   0.1
	Q0P8U5_TED01              	     4	   165	    51.9
	PF04101	Glyco_tran_28_C 	   188	   344	    32.1

A0A0A8WS75	UDP-2,4-DIACETAMIDO-2,4,      48.2    6.2e-09   1   1.7   0.0
	Q0P8U5_TED01              	     4	   155	    46.7
	PF04101	Glyco_tran_28_C 	   178	   332	    39.4

A0A0B0IGB8	GLYCOSYL TRANSFERASE FAMI     56.6    1.6e-11   2   2.4   0.1
	Q0P8U5_TED01              	    83	   173	    36.0
	Q0P8U5_TED01              	     4	    83	    18.3
	PF04101	Glyco_tran_28_C 	   196	   352	    45.8

A0A0B2JYL3	POLYSACCHARIDE BIOSYNTHES     55.4    3.7e-11   2   2.2   0.1
	Q0P8U5_TED01              	    76	   168	    29.5
	Q0P8U5_TED01              	     4	    66	    23.9
	PF04101	Glyco_tran_28_C 	   190	   346	    29.4

A0A0D1W1V3	UDP-2,4-DIACETAMIDO-2,4,6     47.6    9.3e-09   1   1.7   0.0
	Q0P8U5_TED01              	     4	   159	    46.4
	PF04101	Glyco_tran_28_C 	   182	   359	    23.9

A0A0F6RCV4	POLYSACCHARIDE BIOSYNTHES     56.0    2.4e-11   2   2.3   0.0
	Q0P8U5_TED01              	    87	   175	    40.4
	Q0P8U5_TED01              	     4	    63	    13.4
	PF04101	Glyco_tran_28_C 	   206	   364	    35.8

A0A0M2UD16	GLYCOSYL TRANSFERASE FAMI     49.0    3.6e-09   2   2.6   0.4
	Q0P8U5_TED01              	    84	   173	    29.6
	Q0P8U5_TED01              	     4	    60	    16.9
	PF04101	Glyco_tran_28_C 	   196	   355	    43.8

A0A0T6UY56	UDP-2,4-DIACETAMIDO-2,4,      45.6    3.9e-08   2   2.2   0.0
	Q0P8U5_TED01              	    87	   175	    26.9
	Q0P8U5_TED01              	     5	    70	    16.5
	PF04101	Glyco_tran_28_C 	   199	   353	    31.1

A0A0W0VWC6	PUTATIVE POLYSACCHARIDE B     45.7    3.6e-08   2   2.6   0.0
	Q0P8U5_TED01              	    54	   169	    28.5
	Q0P8U5_TED01              	     4	    65	    14.9
	PF04101	Glyco_tran_28_C 	   192	   348	      27
	PF13302	Acetyltransf_3  	   364	   499	    42.1
	PF00583	Acetyltransf_1  	   378	   498	    28.6

A0A0X8CRM3	GLYCOSYL TRANSFERASE FAMI     46.0    2.9e-08   1   2.3   3.6
	Q0P8U5_TED01              	     5	   159	    41.9
	PF04101	Glyco_tran_28_C 	   180	   342	    36.9

A0A157S929	UDP-N-ACETYLGLUCOSAMINE--     47.6    9.6e-09   2   2.2   0.0
	Q0P8U5_TED01              	    87	   168	    29.0
	Q0P8U5_TED01              	     6	    59	    16.4
	PF13302	Acetyltransf_3  	   370	   501	    54.2
	PF13420	Acetyltransf_4  	   371	   520	    25.6
	PF13523	Acetyltransf_8  	   374	   507	    33.2
	PF00583	Acetyltransf_1  	   382	   500	    31.6

A0A161S9S6	UDP-2,4-DIACETAMIDO-2,4,      50.2    1.5e-09   2   2.2   0.0
	Q0P8U5_TED01              	    70	   177	    32.9
	Q0P8U5_TED01              	     9	    68	    15.2

A0A162ETV2	GLYCOSYL TRANSFERASE FAMI     55.5    3.4e-11   1   1.5   0.9
	Q0P8U5_TED01              	     4	   154	    54.6
	PF04101	Glyco_tran_28_C 	   174	   336	    25.6

A0A165WQS6	GLYCOSYL TRANSFERASE FAMI     56.0    2.4e-11   1   2.7   0.5
	Q0P8U5_TED01              	     4	   170	    45.6
	PF04101	Glyco_tran_28_C 	   192	   351	    42.8

A0A1D2YT74	UDP-2,4-DIACETAMIDO-2,4,      61.2    5.9e-13   1   2.1   1.4
	Q0P8U5_TED01              	     4	   162	    60.0
	PF04101	Glyco_tran_28_C 	   185	   344	    46.6

A0A1E5D0Q5	UDP-2,4-DIACETAMIDO-2,4,      47.4    1.1e-08   2   2.4   0.0
	Q0P8U5_TED01              	     4	    65	    23.4
	Q0P8U5_TED01              	    74	   159	    21.5
	PF04101	Glyco_tran_28_C 	   199	   324	      22
	PF13302	Acetyltransf_3  	   356	   487	    42.4
	PF00583	Acetyltransf_1  	   367	   486	      31

A0A1E7DSL1	UDP-2,4-DIACETAMIDO-2,4,      50.9    9.2e-10   1   2.3   0.4
	Q0P8U5_TED01              	     4	   165	    44.6
	PF04101	Glyco_tran_28_C 	   188	   338	    27.9

A0A1G8DXH2	UDP-2,4-DIACETAMIDO-2,4,6     46.0    2.9e-08   2   2.5   0.0
	Q0P8U5_TED01              	    82	   170	    30.8
	Q0P8U5_TED01              	     4	    54	    12.7
	PF04101	Glyco_tran_28_C 	   194	   351	    32.6

A0A1G9YNE0	UDP-2,4-DIACETAMIDO-2,4,6     48.9    3.7e-09   1   1.9   1.0
	Q0P8U5_TED01              	     5	   156	    47.9
	PF04101	Glyco_tran_28_C 	   179	   340	      22

A0A1H2EJT2	UDP-2,4-DIACETAMIDO-2,4,6     45.7    3.6e-08   2   2.4   0.0
	Q0P8U5_TED01              	    83	   170	    25.5
	Q0P8U5_TED01              	     4	    60	    17.7
	PF04101	Glyco_tran_28_C 	   195	   360	    38.9

A0A1H7CLH7	UDP-2,4-DIACETAMIDO-2,4,6     47.9    7.7e-09   2   2.3   0.2
	Q0P8U5_TED01              	    81	   169	    30.3
	Q0P8U5_TED01              	     4	    81	    15.4
	PF04101	Glyco_tran_28_C 	   191	   344	    26.1

A0A1H9RUH9	UDP-2,4-DIACETAMIDO-2,4,6     51.3      7e-10   1   1.3   0.0
	Q0P8U5_TED01              	     2	   148	    50.7

A0A1I5LLW9	UDP-2,4-DIACETAMIDO-2,4,6    113.0    5.9e-29   1   1.4   0.6
	Q0P8U5_TED01              	     5	   146	   112.3

A0A1I6GJ71	UDP-2,4-DIACETAMIDO-2,4,6     49.3    2.8e-09   2   2.2   0.0
	Q0P8U5_TED01              	    90	   179	    38.4
	Q0P8U5_TED01              	    18	    79	     8.9
	PF04101	Glyco_tran_28_C 	   203	   364	    42.9

A0A1K1NT35	UDP-2,4-DIACETAMIDO-2,4,6     48.8    3.9e-09   2   2.2   0.0
	Q0P8U5_TED01              	    74	   168	    32.6
	Q0P8U5_TED01              	     4	    64	    14.2
	PF04101	Glyco_tran_28_C 	   190	   344	    30.1

A0A1Q8Z5U6	UDP-2,4-DIACETAMIDO-2,4,      47.1    1.3e-08   2   2.2   0.0
	Q0P8U5_TED01              	    89	   168	    31.6
	Q0P8U5_TED01              	     4	    64	    13.3

A0A1S6U679	UDP-2,4-DIACETAMIDO-2,4,     182.7    1.8e-50   1   1.4   4.7
	Q0P8U5_TED01              	    12	   148	   182.0

A0A1V2A4L0	UDP-2,4-DIACETAMIDO-2,4,      50.1    1.6e-09   2   2.7   1.2
	Q0P8U5_TED01              	    82	   165	    34.7
	Q0P8U5_TED01              	     4	    75	    13.4
	PF04101	Glyco_tran_28_C 	   188	   343	    30.2

A0A1W6CID0	UDP-2,4-DIACETAMIDO-2,4,      47.0    1.5e-08   1   2.2   0.0
	Q0P8U5_TED01              	     7	   137	    41.8

A0A222MYN8	UDP-2,4-DIACETAMIDO-2,4,     231.9    1.1e-65   1   1.5   5.1
	Q0P8U5_TED01              	     4	   142	   230.9

A0A238TCQ3	UDP-2,4-DIACETAMIDO-2,4,6     45.7    3.6e-08   2   3.3   0.1
	Q0P8U5_TED01              	    83	   172	    28.8
	Q0P8U5_TED01              	     4	    58	    11.4
	PF04101	Glyco_tran_28_C 	   201	   365	    29.3
	PF13302	Acetyltransf_3  	   374	   505	    61.5
	PF00583	Acetyltransf_1  	   385	   504	    35.4

A0A239DJB3	UDP-2,4-DIACETAMIDO-2,4,6     50.4    1.3e-09   1   1.2   0.0
	Q0P8U5_TED01              	     4	   151	    49.9
	PF04101	Glyco_tran_28_C 	   183	   325	    31.8

A0A2I2A688	UDP-2,4-DIACETAMIDO-2,4,      47.1    1.3e-08   2   2.3   0.1
	Q0P8U5_TED01              	     4	    80	    22.8
	Q0P8U5_TED01              	   109	   197	    22.2
	PF04101	Glyco_tran_28_C 	   222	   358	    28.6

A0A2K9LNM5	UDP-2,4-DIACETAMIDO-2,4,      58.2    4.9e-12   2   2.3   0.0
	Q0P8U5_TED01              	    88	   175	    39.5
	Q0P8U5_TED01              	     5	    61	    16.5
	PF04101	Glyco_tran_28_C 	   200	   361	    54.1

A0A317KYT5	UDP-2,4-DIACETAMIDO-2,4,      45.7    3.7e-08   1   2.3   0.1
	Q0P8U5_TED01              	     7	   167	    40.8
	PF04101	Glyco_tran_28_C 	   189	   348	      23

A0A366WEG8	UDP-2,4-DIACETAMIDO-2,4,      47.2    1.2e-08   2   2.5   0.0
	Q0P8U5_TED01              	    92	   172	    28.1
	Q0P8U5_TED01              	     4	    64	    16.5
	PF04101	Glyco_tran_28_C 	   189	   354	    25.8

A0A378QCQ3	UNDECAPRENYLDIPHOSPHO-MUR     51.2    7.4e-10   2   2.5   0.0
	Q0P8U5_TED01              	    80	   170	    35.2
	Q0P8U5_TED01              	     4	    76	    13.5
	PF04101	Glyco_tran_28_C 	   197	   359	    42.3
	PF13302	Acetyltransf_3  	   369	   534	    41.4
	PF13523	Acetyltransf_8  	   374	   540	    33.3
	PF00583	Acetyltransf_1  	   380	   533	      22

A0A3D9ITI7	UDP-2,4-DIACETAMIDO-2,4,      54.1    9.3e-11   1   1.9   0.0
	Q0P8U5_TED01              	     4	   161	    51.9
	PF04101	Glyco_tran_28_C 	   184	   339	    32.9

A0A3G9GVF3	UDP-6-DEOXY-ALTDINAC HYDR    114.1    2.8e-29   1   1.4   0.1
	Q0P8U5_TED01              	     5	   147	   113.2
	PF13302	Acetyltransf_3  	   312	   444	    52.8
	PF13420	Acetyltransf_4  	   317	   452	    28.9
	PF00583	Acetyltransf_1  	   323	   443	    46.5

A0A3M3E9K4	GLYCOSYL TRANSFERASE FAMI     49.1    3.3e-09   2   2.5   0.0
	Q0P8U5_TED01              	    85	   172	    34.4
	Q0P8U5_TED01              	     4	    57	    12.1
	PF04101	Glyco_tran_28_C 	   196	   353	    41.5

A0A3S0TXA4	UDP-2,4-DIACETAMIDO-2,4,      50.1    1.6e-09   2   2.7   0.8
	Q0P8U5_TED01              	    75	   165	    31.1
	Q0P8U5_TED01              	     4	    69	    16.5
	PF04101	Glyco_tran_28_C 	   188	   349	    31.9

A0A3S9B1Q5	UDP-2,4-DIACETAMIDO-2,4,      55.0    5.1e-11   2   2.2   0.0
	Q0P8U5_TED01              	    82	   175	    37.2
	Q0P8U5_TED01              	    11	    63	    15.6

A0A4P6VSL8	UDP-2,4-DIACETAMIDO-2,4,      47.3    1.2e-08   1   1.3   0.0
	Q0P8U5_TED01              	     4	   152	    46.7

A0A4R3XZA8	UDP-2,4-DIACETAMIDO-2,4,      47.3    1.2e-08   2   2.3   0.0
	Q0P8U5_TED01              	    81	   169	    32.0
	Q0P8U5_TED01              	     4	    61	    12.9
	PF04101	Glyco_tran_28_C 	   192	   349	    28.4
	PF13302	Acetyltransf_3  	   363	   494	    48.8
	PF00583	Acetyltransf_1  	   373	   493	    24.3

A0A4S4ATD4	UDP-2,4-DIACETAMIDO-2,4,      46.3    2.4e-08   2   2.2   0.0
	Q0P8U5_TED01              	   101	   180	    31.3
	Q0P8U5_TED01              	     7	    59	    12.8

A0A4U7BJH8	UDP-2,4-DIACETAMIDO-2,4,     194.4    4.4e-54   1   1.3   2.2
	Q0P8U5_TED01              	     4	   143	   193.8

A0A4V2V2U6	UDP-2,4-DIACETAMIDO-2,4,      56.4    1.8e-11   2   2.3   0.0
	Q0P8U5_TED01              	    85	   172	    33.7
	Q0P8U5_TED01              	     7	    70	    20.5
	PF04101	Glyco_tran_28_C 	   192	   354	    43.9

A0A511VBA0	UDP-2,4-DIACETAMIDO-2,4,6     56.5    1.6e-11   1   1.6   0.0
	Q0P8U5_TED01              	     4	   159	    55.3
	PF04101	Glyco_tran_28_C 	   182	   362	    28.4

A0A511W383	UDP-2,4-DIACETAMIDO-2,4,6     47.2    1.2e-08   1   1.6   0.0
	Q0P8U5_TED01              	     4	   151	    46.0
	PF04101	Glyco_tran_28_C 	   179	   337	    24.1
	PF04007	DUF354          	   185	   277	    22.2

A0A5B8Z8C5	UDP-2,4-DIACETAMIDO-2,4,      51.7    5.2e-10   2   2.3   1.1
	Q0P8U5_TED01              	    84	   174	    31.7
	Q0P8U5_TED01              	     4	    77	    18.6
	PF04101	Glyco_tran_28_C 	   196	   354	    33.8

A0A5R8Y6D0	UDP-2,4-DIACETAMIDO-2,4,      48.1    6.7e-09   2   2.3   0.0
	Q0P8U5_TED01              	    76	   182	    29.6
	Q0P8U5_TED01              	    12	    80	    16.4

A0A6B3TKC8	UDP-2,4-DIACETAMIDO-2,4,      55.3    4.1e-11   2   2.5   0.1
	Q0P8U5_TED01              	    82	   168	    41.7
	Q0P8U5_TED01              	     4	    68	    10.9
	PF04101	Glyco_tran_28_C 	   191	   351	    41.9

A0A6B8RD37	UDP-2,4-DIACETAMIDO-2,4,      49.6    2.3e-09   2   2.2   0.1
	Q0P8U5_TED01              	    67	   178	    33.7
	Q0P8U5_TED01              	     4	    70	    13.8
	PF04101	Glyco_tran_28_C 	   209	   359	    30.4

A0A6C1B449	UDP-2,4-DIACETAMIDO-2,4,      49.4    2.7e-09   1   1.6   0.0
	Q0P8U5_TED01              	     4	   155	    48.2
	PF04101	Glyco_tran_28_C 	   179	   338	    33.2

A0A6G5R1K9	UDP-2,4-DIACETAMIDO-2,4,     183.5      1e-50   1   1.4   1.1
	Q0P8U5_TED01              	    21	   157	   182.6

A0A6L8V641	UDP-2,4-DIACETAMIDO-2,4,      48.4    5.3e-09   2   2.4   0.0
	Q0P8U5_TED01              	    53	   169	    26.7
	Q0P8U5_TED01              	     4	    64	    19.6
	PF04101	Glyco_tran_28_C 	   192	   357	    32.2

A0A6M1Y9K1	UDP-2,4-DIACETAMIDO-2,4,      54.9    5.3e-11   1   1.6   0.0
	Q0P8U5_TED01              	    10	   147	    53.7

A0A7L8V7Z6	UDP-2,4-DIACETAMIDO-2,4,     149.7    2.9e-40   1   1.6   3.2
	Q0P8U5_TED01              	     8	   147	   149.7

A0A7R6W623	GLYCOSYL TRANSFERASE FAMI     48.2    6.3e-09   2   2.2   0.0
	Q0P8U5_TED01              	    83	   170	    25.3
	Q0P8U5_TED01              	     4	    79	    20.7
	PF04101	Glyco_tran_28_C 	   196	   345	    31.5

A0A7W4WG64	UDP-2,4-DIACETAMIDO-2,4,      47.4    1.1e-08   2   2.2   0.0
	Q0P8U5_TED01              	    62	   177	    29.0
	Q0P8U5_TED01              	     4	    75	    16.6
	PF04101	Glyco_tran_28_C 	   201	   354	    22.6

A0A7Z2VQR2	UDP-2,4-DIACETAMIDO-2,4,      47.6    9.2e-09   1   1.4   0.0
	Q0P8U5_TED01              	     4	   155	    46.9
	PF04101	Glyco_tran_28_C 	   177	   335	    41.4

A0A839VA76	UDP-2,4-DIACETAMIDO-2,4,      50.9    8.8e-10   2   2.2   0.0
	Q0P8U5_TED01              	   107	   184	    33.8
	Q0P8U5_TED01              	    12	    72	    15.1
	PF04101	Glyco_tran_28_C 	   208	   375	    31.9

A0A841TWE5	UDP-2,4-DIACETAMIDO-2,4,      46.2    2.6e-08   1   1.7   0.0
	Q0P8U5_TED01              	     4	   161	    44.6
	PF04101	Glyco_tran_28_C 	   184	   343	    38.3

A0A842J4T6	UDP-2,4-DIACETAMIDO-2,4,     179.5    1.8e-49   1   1.4   0.5
	Q0P8U5_TED01              	    12	   145	   178.6

A0A846RQE9	UDP-2,4-DIACETAMIDO-2,4,      47.3    1.2e-08   2   2.2   0.0
	Q0P8U5_TED01              	   163	   248	    33.2
	Q0P8U5_TED01              	    79	   138	    12.0

A0A8J2TSJ7	UDP-2,4-DIACETAMIDO-2,4,      48.0    6.9e-09   2   2.6   0.0
	Q0P8U5_TED01              	    79	   169	    26.3
	Q0P8U5_TED01              	     4	    77	    19.1
	PF04101	Glyco_tran_28_C 	   189	   351	      30
	PF00551	Formyl_trans_N  	   379	   495	    37.6

A0A916CSZ7	UDP-2,4-DIACETAMIDO-2,4,      46.0      3e-08   2   2.3   0.0
	Q0P8U5_TED01              	    78	   169	    31.2
	Q0P8U5_TED01              	     4	    68	    12.4
	PF13302	Acetyltransf_3  	   363	   494	    31.4
	PF00551	Formyl_trans_N  	   539	   647	    30.7

A0A917FNE4	UDP-2,4-DIACETAMIDO-2,4,      46.5    2.1e-08   1   1.6   0.0
	Q0P8U5_TED01              	     4	   160	    45.4

A0A917JR45	N-ACETYLTRANSFERASE DOMAI     57.8    6.6e-12   2   2.9   0.1
	Q0P8U5_TED01              	     4	    69	    28.0
	Q0P8U5_TED01              	    73	   169	    26.2
	PF04101	Glyco_tran_28_C 	   191	   305	    27.7
	PF13302	Acetyltransf_3  	   363	   498	    35.6

A0A917S4A8	UDP-2,4-DIACETAMIDO-2,4,      45.8    3.5e-08   1   2.4   0.2
	Q0P8U5_TED01              	     5	   169	    38.1
	PF04101	Glyco_tran_28_C 	   190	   349	    34.6

A0A919WYN1	UDP-2,4-DIACETAMIDO-2,4,      56.1    2.3e-11   1   2.4   0.4
	Q0P8U5_TED01              	     4	   167	    48.8
	PF04101	Glyco_tran_28_C 	   190	   349	    40.6

A0A926NIY0	UDP-2,4-DIACETAMIDO-2,4,      45.9    3.1e-08   2   2.4   0.2
	Q0P8U5_TED01              	    74	   165	    22.8
	Q0P8U5_TED01              	     4	    70	    20.9

A0A927CXR3	UDP-2,4-DIACETAMIDO-2,4,      47.0    1.4e-08   1   2.2   0.0
	Q0P8U5_TED01              	     4	   154	    44.7
	PF04101	Glyco_tran_28_C 	   177	   341	    40.3

A0A927MI10	UDP-2,4-DIACETAMIDO-2,4,      56.7    1.4e-11   1   2.4   0.6
	Q0P8U5_TED01              	     4	   166	    50.0
	PF04101	Glyco_tran_28_C 	   189	   348	    50.1

A0A942PF16	UDP-2,4-DIACETAMIDO-2,4,      50.5    1.2e-09   1   1.4   0.0
	Q0P8U5_TED01              	    13	   166	    49.7
	PF04101	Glyco_tran_28_C 	   189	   348	    26.5

A0A974NPW1	UDP-2,4-DIACETAMIDO-2,4,      48.0    6.9e-09   2   2.3   0.1
	Q0P8U5_TED01              	    82	   170	    33.7
	Q0P8U5_TED01              	     4	    64	    12.2
	PF04101	Glyco_tran_28_C 	   192	   352	      24

A0A974XR56	UDP-2,4-DIACETAMIDO-2,4,      55.4    3.8e-11   2   2.5   0.1
	Q0P8U5_TED01              	    87	   166	    28.5
	Q0P8U5_TED01              	     4	    60	    24.4
	PF04101	Glyco_tran_28_C 	   196	   339	    26.7
	PF13302	Acetyltransf_3  	   362	   493	    38.5

A0A9J6R9Y2	UDP-2,4-DIACETAMIDO-2,4,      46.9    1.5e-08   1   2.8   0.2
	Q0P8U5_TED01              	     4	   156	    46.9

A0A9Q6PRP6	UDP-2,4-DIACETAMIDO-2,4,      46.5      2e-08   2   2.8   2.0
	Q0P8U5_TED01              	    71	   174	    31.5
	Q0P8U5_TED01              	     4	    82	    13.4
	PF13302	Acetyltransf_3  	   354	   486	    40.8
	PF13420	Acetyltransf_4  	   357	   492	    28.6
	PF00583	Acetyltransf_1  	   364	   485	    22.1

A0A9Y2AJ43	UDP-2,4-DIACETAMIDO-2,4,      51.3      7e-10   2   2.5   0.9
	Q0P8U5_TED01              	    76	   168	    32.9
	Q0P8U5_TED01              	     5	    60	    16.1
	PF04101	Glyco_tran_28_C 	   190	   341	      42

A4F0Q8	PROBABLE POLYSACCHARIDE BIOSY     47.8    8.2e-09   2   2.3   0.0
	Q0P8U5_TED01              	    95	   170	    36.8
	Q0P8U5_TED01              	     4	    60	     8.7
	PF04101	Glyco_tran_28_C 	   193	   350	    36.6

A7H0H4	UDP-2,4-DIACETAMIDO-2,4, 6-TR    174.6    5.7e-48   1   1.7   1.1
	Q0P8U5_TED01              	    12	   148	   174.0

B9KDJ7	UDP-2,4-DIACETAMIDO-2,4, 6-TR    262.2    5.1e-75   1   1.3   3.2
	Q0P8U5_TED01              	     4	   140	   261.5

D0IC30	N-ACETYLNEURAMINATE CYTIDYLYL     45.8    3.3e-08   2   2.5   0.1
	Q0P8U5_TED01              	     4	    67	    24.6
	Q0P8U5_TED01              	    80	   161	    18.6
	PF04101	Glyco_tran_28_C 	   188	   335	    37.1
	PF13302	Acetyltransf_3  	   357	   488	      47
	PF00583	Acetyltransf_1  	   370	   487	    34.7
	PF13673	Acetyltransf_10 	   390	   502	    25.9

D1B553	PSEUDAMINIC ACID BIOSYNTHESIS    155.1      6e-42   1   1.3   1.0
	Q0P8U5_TED01              	     4	   140	   154.4

E0UT86	PSEUDAMINIC ACID BIOSYNTHESIS    110.2    4.5e-28   1   2.0   3.3
	Q0P8U5_TED01              	     9	   151	   109.3

E6TS78	PSEUDAMINIC ACID BIOSYNTHESIS     45.5    4.3e-08   1   1.5   1.0
	Q0P8U5_TED01              	     7	   156	    44.6

F6DNQ0	PSEUDAMINIC ACID BIOSYNTHESIS     48.0      7e-09   1   2.3   0.5
	Q0P8U5_TED01              	     4	   173	    36.4
	PF04101	Glyco_tran_28_C 	   196	   354	    44.4

I0JI42	POLYSACCHARIDE BIOSYNTHESIS P     62.0    3.5e-13   1   1.3   0.0
	Q0P8U5_TED01              	     4	   155	    61.3

J0UYT4	PSEUDAMINIC ACID BIOSYNTHESIS    130.1    3.2e-34   1   1.4   3.0
	Q0P8U5_TED01              	     4	   145	   129.3

K6D5W0	PSEUDAMINIC ACID BIOSYNTHESIS     45.8    3.5e-08   2   2.9   0.0
	Q0P8U5_TED01              	    89	   170	    27.3
	Q0P8U5_TED01              	     4	    69	    14.9
	PF04101	Glyco_tran_28_C 	   192	   351	    27.2
	PF04007	DUF354          	   196	   295	    25.1

Q0P8U5	UDP-2,4-DIACETAMIDO-2,4,6-TRIDE    310.0    8.6e-90   1   1.5   2.8
	Q0P8U5_TED01              	     4	   140	   310.0

Q6LNP0	HYPOTHETICAL FLMD {ECO:000031     48.6    4.8e-09   2   2.6   0.3
	Q0P8U5_TED01              	    72	   167	    34.2
	Q0P8U5_TED01              	     4	    63	    11.7
	PF13302	Acetyltransf_3  	   368	   502	    35.6
	PF00583	Acetyltransf_1  	   381	   501	    32.6
	PF13673	Acetyltransf_10 	   402	   512	    25.5

T0KQG0	UDP-2,4-DIACETAMIDO-2,4, 6-TR    110.3    4.3e-28   1   1.4   4.1
	Q0P8U5_TED01              	     4	   145	   109.5

V7IFZ8	PSEUDAMINIC ACID BIOSYNTHESIS     48.3    5.9e-09   2   2.3   0.0
	Q0P8U5_TED01              	   116	   195	    30.1
	Q0P8U5_TED01              	    10	    65	    15.8
	PF04101	Glyco_tran_28_C 	   233	   384	    24.6
	PF13302	Acetyltransf_3  	   390	   523	    63.7
	PF00583	Acetyltransf_1  	   401	   522	    35.1

W5YJL7	POLYSACCHARIDE BIOSYNTHESIS P     46.4    2.2e-08   2   2.3   0.0
	Q0P8U5_TED01              	   102	   178	    32.9
	Q0P8U5_TED01              	     4	    64	    11.3
	PF04101	Glyco_tran_28_C 	   218	   363	    33.1


--- End of Domain architectures ---

--- PaperBLAST literature results (copy to Claude) ---
================================================================================
Protein: VIMSS47187 (E-value: 7.6e-92, Score: 310.0)
Mentioned as: Cj1312
Description: possible flagellar protein
Organism: Campylobacter jejuni subsp. jejuni NCTC 11168
PMID: 27986835
Source: EuropePMC
Title: Tannerella forsythia strains display different cell-surface nonulosonic acids: biosynthetic pathway characterization and first insight into biological implications
Journal: Glycobiology (2017)
Snippet: pseH (Cj1313) 34 60 N -acetyltransferase Schoenhofen et al. (2006b) Tanf_01235 a C. jejuni pseG (Cj1312) 27 70 UDP-sugar hydrolase Contains PseG consensus sequence ( Rangarajan et al. 2009 , Schoenhofen et al. 2006b) Tanf_01240 H. pylori pseI (HP0178) 49 332 Pseudaminic acid synthase Chou et

================================================================================
Protein: VIMSS47187 (E-value: 7.6e-92, Score: 310.0)
Mentioned as: Cj1312
Description: possible flagellar protein
Organism: Campylobacter jejuni subsp. jejuni NCTC 11168
PMID: 26694450
Source: EuropePMC
Title: A Flagellar Glycan-Specific Protein Encoded by Campylobacter Phages Inhibits Host Cell Growth
Journal: Viruses (2015)
Snippet: Acapsular, kpsM mutant in C. jejuni 11168 [ 25 ] 11168 pseG Aflagellate, pseG ( cj1312 ) mutant in C. jejuni NCTC 11168 This study 81-176 pseA pseA ( cj1316c ) mutant in C. jejuni 81-176 (flagellate, no acetamidino modification) [ 26 ] 11168 pseA pseA

================================================================================
Protein: VIMSS47187 (E-value: 7.6e-92, Score: 310.0)
Mentioned as: Cj1312
Description: possible flagellar protein
Organism: Campylobacter jejuni subsp. jejuni NCTC 11168
PMID: 25574122
Source: EuropePMC
Title: In silico detection of virulence gene homologues in the human pathogen sphingomonas spp
Journal: Evolutionary bioinformatics online (2014)
Snippet: waaC; waaD; waaE; waaF; waaV; porA; peb1 A. Invasion ciaB, ciaC (invasion antigens) Motility Cj0371; Cj1312; Cj1313; flaA; flaB; flaC; flaD; flaG; flgB; flgC; flgD; flgE; flgE2; flgG; flgG2; flgH; flgI; flgK; flhA; flhB; flhF; fliA; fliD; fliE; fliF; fliG; fliH; fliI; fliL; fliM; fliN; fliP;

================================================================================
Protein: VIMSS1957193 (E-value: 4.3e-91, Score: 307.6)
Mentioned as: CJJ81176_1329
Description: flagellar protein, putative
Organism: Campylobacter jejuni subsp. jejuni 81-176
PMID: 40625622
Source: EuropePMC
Title: Genomic analysis and antimicrobial resistance in human- and poultry-derived &lt;i&gt;Campylobacter jejuni&lt;/i&gt; isolates from Hangzhou, China
Journal: Frontiers in microbiology (2025)

================================================================================
Protein: VIMSS3661501 (E-value: 5.1e-90, Score: 304.1)
Mentioned as: C8J_1245
Description: possible flagellar protein
Organism: Campylobacter jejuni subsp. jejuni 81116
PMID: 37768138
Source: EuropePMC
Title: <i>Campylobacter jejuni</i> benefits from the bile salt deoxycholate under low-oxygen condition in a PldA dependent manner
Journal: Gut microbes (2023)
Snippet: involved in electron transport (C8J_0040, NapA, NrfA, NrfH), chemotaxis (CheA), non-heme iron metabolism (C8J_1167), motility (C8J_1245), selenocysteine biosynthesis pathway (SelAB) and arsenic resistance (ArsC and ArsR). These results suggest that the exposure of C. jejuni to DOC at low O 2 levels induces major alterations in

================================================================================
Protein: VIMSS5211639 (E-value: 5.4e-07, Score: 35.3)
Mentioned as: ACICU_00078
Description: spore coat polysaccharide biosynthesis protein, glycosyltransferase
Organism: Acinetobacter baumannii ACICU
PMID: 38524570
Source: EuropePMC
Title: Genotypic and phenotypic mechanisms underlying antimicrobial resistance and synergistic efficacy of rifampicin-based combinations against carbapenem-resistant <i>Acinetobacter baumannii</i>
Journal: Heliyon (2024)
Snippet: 60% of the isolates harbored ACICU_00071 73, ACICU_0007577, ACICU_00080 , and ACICU_00088 89. The genes ACICU_00078 and ACICU_00079 were present in only SK024 ( Fig. 7 ). In addition, a total of 16 biofilm-associated genes - were also revealed. The AdeFGH RND (resistant nodulation division) which

================================================================================
Protein: VIMSS5211639 (E-value: 5.4e-07, Score: 35.3)
Mentioned as: ACICU_00078
Description: spore coat polysaccharide biosynthesis protein, glycosyltransferase
Organism: Acinetobacter baumannii ACICU
PMID: 32084241
Source: EuropePMC
Title: Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications
Journal: PloS one (2020)
Snippet: 0(0.0) 1 4(7.4) 12(27.3) <0.01 ACICU_00077 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01 ACICU_00078 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01 ACICU_00079 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01 ACICU_00080 0(0.0) 0(0.0) 1 0(0.0) 0(0.0) 1 4(7.4) 12(27.3) <0.01 ACICU_00081

================================================================================
Protein: VIMSS3439335 (E-value: 1.7e-06, Score: 33.7)
Mentioned as: Sputcn32_2626
Description: FlaR protein (FlaR)
Organism: Shewanella putrefaciens CN-32
PMID: 30560868
Source: EuropePMC
Title: Spatial arrangement of several flagellins within bacterial flagella improves motility in different environments
Journal: Nature communications (2018)
Snippet: flagellins of S. putrefaciens are glycosylated, we introduced in-frame deletions into the genes encoding PseG (Sputcn32_2626) and Maf-1 (Sputcn32_2630), as the deletion of the orthologs in S. oneidensis results in completely non-glycosylated flagellins 26 , 27 . Immunoblotting analysis of PAGE-separated crude extracts (Supplementary Fig. 2a

================================================================================
Protein: VIMSS5635834 (E-value: 5e-06, Score: 32.1)
Mentioned as: PHZ_c2595
Description: flagellin modification protein FlmD
Organism: Phenylobacterium zucineum HLK1
PMID: 18700039
Source: EuropePMC
Title: Complete genome of Phenylobacterium zucineum--a novel facultative intracellular bacterium isolated from human erythroleukemia cell line K562
Journal: BMC genomics (2008)
Snippet: protein FglI fglI flagellar structure PHZ_c1937 2,169,942 2,170,382 flagellar basal-body protein FlbY flbY flagellar structure PHZ_c2595 2,982,550 2,983,593 flagellin modification protein FlmD flmD regulator PHZ_c2597 2,984,874 2,986,508 flagellin modification protein FlmG flmG regulator PHZ_c2599 2,989,315 2,989,974 flmC; flagellin modification protein FlmC flmC regulator PHZ_c2600 2,990,549 2,989,977


--- End of PaperBLAST literature results ---

--- TED domain information (copy to Claude) ---
Protein_Accession	TED_Domains	Domain_Count	Domain_IDs	Domain_Ranges	Overlap_with_Pfam
Q0P8U5.1	AF-Q0P8U5-F1-model_v4_TED01:4-140	1	AF-Q0P8U5-F1-model_v4_TED01	4-140	100.0%
Q0P8U5.1	AF-Q0P8U5-F1-model_v4_TED02:145-273	1	AF-Q0P8U5-F1-model_v4_TED02	145-273	0

--- End of TED domain information ---

--- Current DESC file (copy to Claude) ---
ID   ShortName
DE   Family description
AU   Bateman A;0000-0002-6982-4660
SE   ECOD:Q0P8U5_TED01
GA   27.00 27.00;
TC   27.00 27.00;
NC   26.90 26.90;
BM   hmmbuild  -o /dev/null HMM SEED
SM   hmmsearch -E 1000 -Z 90746521 --cpu 8 HMM pfamseq
TP   Family
RC   Paper describing PDB structure 3hbm
RN   [1]
RM   19483088
RT   Structural and functional analysis of Campylobacter jejuni PseG: a
RT   udp-sugar	hydrolase from the pseudaminic acid biosynthetic pathway.
RA   Rangarajan ES, Proteau A, Cui Q, Logan SM, Potetinova Z, Whitfield D,
RA   Purisima EO, Cygler M, Matte A, Sulea T, Schoenhofen IC;
RL   J Biol Chem. 2009;284:20989-21000.

--- End of Current DESC file ---